# Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis

> **NCT01018030** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 741 (actual)

## Conditions studied

- Sinusitis, Acute

## Interventions

- **DRUG:** FFNS 110 mcg QD
- **DRUG:** FFNS 110 mcg BID
- **DRUG:** Placebo Nasal Spray

## Key facts

- **NCT ID:** NCT01018030
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-06
- **Primary completion:** 2010-07-01
- **Final completion:** 2010-07-16
- **Target enrollment:** 741 (ACTUAL)
- **Last updated:** 2017-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018030, "Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01018030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*